Several government officials were present at the inauguration of Nektium´s new production facility, which is designed to produce high-quality, standardised botanical extracts this past Friday. The construction of the industrial estate, comprising manufacturing plant, advanced laboratories and an elegant office complex, and spread over 10,000 square metres, began in 2015 and has been fully operational since 2018. It has a production capacity five times bigger than previous facilities.
"Researching innovative ingredients and producing them here in our facilities is the core of the business. It was a logical consequence to emphasise both these pillars of Nektium", says Dr Miguel Jiménez, founder of Nektium Pharma. He consequently expanded the R&D team and further opted for a new production plant with a higher production capacity.
This decision was honoured by the Spanish secretary of state for commerce, Xiana Méndez, who attended the inauguration last Friday amongst other representatives of the government and thanked Jiménez for making the Canary Islands his primary business location.
"We experience more demand than ever for our botanical extracts and are very happy with the proactive choice of Nektium´s CEO Dr Miguel Jiménez to invest in a new manufacturing facility and advanced laboratories, to increase the production capacity and ability to conduct our own scientific research in-house. This allowed us to expand sales of our principal products such as Rhodiolife, Xanthigen and Zynamite to many parts of the world," said Annette Badenhorst, Nektium’s sales & marketing director.